| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |